Personal Capital Advisors Corp Moderna, Inc. Transaction History

Personal Capital Advisors Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$117.13 - $176.59 $186,353 - $280,954	-1,591 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $23,648 - $43,954	-187 Reduced 10.52%	1,591 $274,000
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $60,068 - $98,023	266 Added 17.59%	1,778 $452,000
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $10,429 - $22,770	-47 Reduced 3.01%	1,512 $582,000
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $202,529 - $366,333	1,559 New	1,559 $366,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

Stay updated on Personal Capital Advisors Corp with notifications on news.